Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ismael Fernandez-Fernandez"'
Autor:
Peter Carr, Ian Blanco-Mavillard, Miguel Angel Rodríguez-Calero, Ismael Fernandez-Fernandez, Paulo Santos-Costa, Gaizka Parra-García
Publikováno v:
BMJ Open, Vol 14, Iss 7 (2024)
Objective Billions of vascular access devices (VADs) are inserted annually for intravenous therapy worldwide. However, their use is not without challenges. Facilitating the process and enhancing results, hospital authorities have created vascular acc
Externí odkaz:
https://doaj.org/article/6fc94d93f1304a0e9f526565f7c783e1
Autor:
Ian Blanco-Mavillard, Ismael Fernandez-Fernandez, Joan Ernest de Pedro-Gomez, José Luis Cobo-Sánchez, Raquel Pelayo-Alonso, Noelia Mancebo-Salas
Publikováno v:
BMJ Open, Vol 12, Iss 9 (2022)
Introduction Haemodialysis patients with central venous catheter (HD-CVC) are at increased risk of exit site infections (ESIs) and catheter-related bloodstream infections, causing an increase of hospitalisation, morbidity and mortality rates. The mai
Externí odkaz:
https://doaj.org/article/985156278b2a4bb2ac3ab62101ecbf74
Autor:
José Luis Cobo-Sánchez, Ian Blanco-Mavillard, Raquel Pelayo-Alonso, Noelia Mancebo-Salas, Ismael Fernandez-Fernandez, Joan Ernest De Pedro-Gomez
Publikováno v:
BMJ Open. 12:e065724
IntroductionHaemodialysis patients with central venous catheter (HD-CVC) are at increased risk of exit site infections (ESIs) and catheter-related bloodstream infections, causing an increase of hospitalisation, morbidity and mortality rates. The main
Autor:
Ian Blanco-Mavillard, Celia Personat-Labrador, Enrique Castro-Sánchez, Miguel Ángel Rodríguez-Calero, Ismael Fernández-Fernández, Peter J. Carr, Victoria Armenteros-Yeguas, Gaizka Parra-García, Joan de Pedro-Gómez
Publikováno v:
Journal of Infection and Public Health, Vol 16, Iss 12, Pp 1994-2000 (2023)
Background: Around 1 billion peripheral intravenous catheters (PIVC) fail annually worldwide before prescribed intravenous therapy is completed, resulting in avoidable complications, dissatisfaction, and avoidable costs surging to ∼€4bn. We aimed
Externí odkaz:
https://doaj.org/article/2f5614cc3d6e4238bdfd8cb20f971283
Autor:
Ian Blanco-Mavillard, Enrique Castro-Sánchez, Gaizka Parra-García, Miguel Ángel Rodríguez-Calero, Miquel Bennasar-Veny, Ismael Fernández-Fernández, Harri Lorente-Neches, Joan de Pedro-Gómez
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 11, Iss 1, Pp 1-9 (2022)
Abstract Background Peripheral intravenous catheters (PIVC) are commonly used in hospital worldwide. However, PIVC are not exempt from complications. Catheter-related bloodstream infections (CRBSI) increase morbidity and mortality rates, and costs fo
Externí odkaz:
https://doaj.org/article/87195cdfb5bd43dabe4b3efc9aa2a0c3
Autor:
Ian Blanco-Mavillard, Miguel Ángel Rodríguez-Calero, Joan de Pedro-Gómez, Gaizka Parra-García, Ismael Fernández-Fernández, Enrique Castro-Sánchez
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 8, Iss 1, Pp 1-11 (2019)
Abstract Background Peripheral intravenous catheters (PIVCs) are the most widely used invasive devices among inpatients. Catheter-related bloodstream infections (CRBSI) are serious yet preventable events for patients. Although the contribution of PIV
Externí odkaz:
https://doaj.org/article/a364ed99ba8f41fd9663837d43a36af5
Autor:
Ian Blanco-Mavillard, Gaizka Parra-García, Ismael Fernández-Fernández, Miguel Ángel Rodríguez-Calero, Celia Personat-Labrador, Enrique Castro-Sánchez
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0240086 (2020)
BackgroundPeripheral intravenous catheters (PIVCs) are the most widely used invasive devices worldwide. Up to 42% of PIVCs are prematurely removed during intravenous therapy due to failure. To date, there have been few systematic attempts in European
Externí odkaz:
https://doaj.org/article/b1e3b1e7ae0d4f43bda13fdc19919ee6